A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo | MicrobiomeTrials← Back to trialsNCT07533019
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-14Est. Completion: 2027-05
Enrollment target: 66 participants Locations- Medical Dermatology Specialists, Phoenix, Arizona, United States
- Saguaro Dermatology - Phoenix, Phoenix, Arizona, United States
- Center For Dermatology Clinical Research, Inc., Fremont, California, United States
- Northridge Clinical Trials, Northridge, California, United States
- Cura Clinical Research - Oxnard, Oxnard, California, United States
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita, California, United States
- Health Clinical Research, LLC, Miami, Florida, United States
- K2 Medical Research - Tampa, Tampa, Florida, United States
- Advanced Medical Research, PC., Sandy Springs, Georgia, United States
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Revival Research Institute, LLC, Troy, Michigan, United States
- Stracskin, Portsmouth, New Hampshire, United States
- Equity Medical, The Bronx, New York, United States
- Accurate Clinical Research, Inc, Humble, Texas, United States
Other microbiome trials you might be interested in
VitiligoAtopic DermatitisAlopecia AreataHidradenitis Suppurativa (HS)
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatol…
New York, United StatesEst. completion Aug 3, 2041
Non-segmental Vitiligo
The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the …
Birmingham, United StatesEst. completion Jun 6, 2028
Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio, Texas, United StatesJordan Valley Dermatology & Research Center, South Jordan, Utah, United StatesClinical Research Partners, LLC, Richmond, Virginia, United StatesAnima Diepenbeek, Diepenbeek, BelgiumUZ Gent, Ghent, BelgiumCentre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, BelgiumINTERMED Groupe Sante, Chicoutimi, CanadaDermEffects, London, CanadaDar Clinical Research - Ottawa - Hunt Club Road, Ottawa, CanadaThe Centre for Dermatology, Richmond Hill, CanadaResearch Toronto, Toronto, CanadaSIMa Recherche, Verdun, CanadaPeking University People's Hospital, Beijing, ChinaHangzhou Third People's Hospital, Hangzhou, ChinaShanghai Skin Disease Hospital, Shanghai, ChinaThe University of Hong Kong-Shenzhen Hospital, Shenzhen, ChinaCentrum Badan Klinicznych PI-House sp. z o.o., Gdansk, PolandDiamond Clinic, Krakow, PolandDermedic Jacek Zdybski, Ostrowiec Świętokrzyski, PolandCentrum Medyczne Ginemedica, Wroclaw, Poland